Simcere pharmaceutical

 Founded on 28th March 1995, Simcere has swiftly evolved from a pure pharmaceutical distributor into a leading pharmaceutical manufacturer and supplier in China's rapidly growing pharmaceutical market. Simcere currently operates one research and development center, two nationwide sale and marketing subsidiaries and four GMP manufacturing facilities. It has approximately 4,300 employees in China. 

Innovation is the key driver of our growth towards excellence. In recent years, we have refined our strategy to focus on innovative pharmaceuticals and first-to-market generics.
Simcere's sales and marketing network has established a deep market penetration and broad coverage across China. Our current portfolio is comprised of innovative pharmaceuticals, first-to-market generics and branded generics in five core disease areas ¨C oncology, neurology, cardiovascular/cerebrovascular, inflammation and infectious diseases, reflected in 50+ product combinations.Innovation is the key d... [Introduce]